PFIZER REPORTS FIRST-QUARTER 2019 RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St futures flat after tech rout; Iran tensions, retail earnings in focus
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Target raises full-year sales forecast amid ongoing turnaround drive
- Global bond rout pauses as sovereign yields back off multi-decade highs
- Lowe's slashes full-year sales outlook amid DIY spending pressure
- Tech selloff weighs down Wall Street as bond yields climb
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Francisco Partners to acquire Weave Communications for $650M
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Goldman Sachs to acquire real estate company LCN for up to $410M
Pfizer (PFE) Tops Q1 EPS by 10c; Bumps EPS Outlook
April 30, 2019 6:46 AM EDTPfizer (NYSE: PFE) reported Q1 EPS of $0.85, $0.10 better than the analyst estimate of $0.75. Revenue for the quarter came in at $13.1 billion versus the consensus estimate of $12.99 billion.
GUIDANCE:
Pfizer raises midpoint of FY2019 EPS by 1 cent to $2.83-$2.93, versus the consensus of $2.89.... More
